Author

Alok R. Khandelwal

Feist-Weiller Cancer CenterORCID 0000-0002-6217-233XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Cherie‐Ann O. NathaniD· 1 shared Chun LiiD· 1 shared Jorge Silvio GutkindiD· 1 shared Omar E. FrancoiD· 1 shared Priyatosh NathiD· 1 shared Srivatsa Surya VasudevaniD· 1 shared Tara Moore‐Medlin· 1 shared Victor Albornoz AlvareziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cherie‐Ann O. NathanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNeoplasiaPeer-reviewedAug 8, 2026

mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment.

Priyatosh Nath, Alok R. Khandelwal, Chun Li…·Cherie‐Ann O. Nathan

This study shows that mTOR inhibition with everolimus enhances antitumor immune responses in TP53-mutant HNSCC by altering the tumor microenvironment.

DOI 10.1016/j.neo.2026.101350

mousebulk RNA-seq

𝕏 PostBluesky